Tag Archives: Conference Call Details

Business, Finance, Occupation & Industry

Perficient to Announce First Quarter 2013 Results and Host Conference Call on May 9

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Perficient to Announce First Quarter 2013 Results and Host Conference Call on May 9

ST. LOUIS–(BUSINESS WIRE)– Perficient, Inc. (NAS: PRFT) , a leading information technology consulting firm serving Global 2000 and other large enterprise customers throughout North America, announced today it will host a conference call on Thursday, May 9, at 10 a.m. Eastern, to discuss the Company’s first quarter 2013 results.

The Company’s news release with the results will be made available before the call.

Webcast and Conference Call Details

The call will be webcast by CCBN and can be accessed via Perficient’s website www.perficient.com under the Investor Relations section. The webcast also is being distributed over CCBN‘s Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN‘s individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in CCBN‘s Individual Investor Network. Institutional investors can access the call via CCBN‘s password-protected event management site, StreetEvents (www.streetevents.com).

Analysts and investors wishing to ask questions during the call’s Q&A session can access the call as follows:

Toll-Free: 877-280-4960
International: 857-244-7317
Passcode: 21861199

Investors are advised to dial into the call at least 10 minutes prior to the call to register.

About Perficient

Perficient is a leading information technology consulting firm serving Global 2000 and enterprise customers throughout North America. Perficient’s professionals serve clients from a network of offices across North America and three offshore locations, in Eastern Europe, India, and China. Perficient helps clients use Internet-based technologies to improve productivity and competitiveness, strengthen relationships with customers, suppliers and partners, and reduce information technology costs. Perficient, traded on the Nasdaq Global Select Market(SM), is a member of the Russell 2000® index and the S&P SmallCap 600 index. Perficient is an award-winning “Premier Level” IBM business partner, a TeamTIBCO partner, a Microsoft National Systems Integrator and Gold Certified Partner, an EMC Select Services Team Partner, and an Oracle Platinum Partner. For more information, please visit www.perficient.com.

Safe Harbor Statement

Some of the statements contained in this

From: http://www.dailyfinance.com/2013/04/11/perficient-to-announce-first-quarter-2013-results-/

Business, Finance, Occupation & Industry

Illumina to Announce First Quarter 2013 Financial Results on Monday, April 22, 2013

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Illumina to Announce First Quarter 2013 Financial Results on Monday, April 22, 2013

SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NAS: ILMN) today announced that it will issue results for first quarter 2013 following the close of market on Monday, April 22, 2013.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time), Jay Flatley, President and Chief Executive Officer, Marc Stapley, Senior Vice President and Chief Financial Officer, and Christian Henry, Senior Vice President and General Manager, Genomic Solutions, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Monday, April 22, 2013. Interested parties may listen to the call by dialing 888.679.8033 (passcode: 58226131), or if outside North America, by dialing +1.617.213.4846 (passcode: 58226131). Individuals may access the live teleconference in the Investor Relations section of Illumina’s web site under the “Company” tab at www.illumina.com.

A replay of the conference call will be available from 4:00 pm Pacific Time (7:00 pm Eastern Time) on April 22, 2013 through April 29, 2013 by dialing 888.286.8010 (passcode: 31374623), or if outside North America, by dialing +1.617.801.6888 (passcode: 31374623).

About Illumina

Illumina (http://www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

Illumina, Inc.
Investors:
Rebecca Chambers
858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple
858-882-6822
pr@illumina.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article Illumina to Announce First Quarter 2013 Financial Results on Monday, April 22, 2013 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for …read more

Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

ServiceNow to Announce First Quarter 2013 Financial Results on Wednesday, April 24, 2013

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

ServiceNow to Announce First Quarter 2013 Financial Results on Wednesday, April 24, 2013

SAN DIEGO–(BUSINESS WIRE)– ServiceNow (NYS: NOW) , the enterprise IT cloud company, today announced it will release financial results for the first quarter ended March 31, 2013 following the close of market on Wednesday, April 24, 2013. ServiceNow will host a conference call and live webcast at 2:00 p.m. Pacific Time (21:00 GMT) that day to discuss the financial results.

Conference Call Details

The conference call will begin at 2:00 p.m. Pacific Time (21:00 GMT) on Wednesday, April 24, 2013. Interested parties may listen to the call by dialing 877.546.5018 (passcode: 78194644), or if outside North America, by dialing 857.244.7550 (passcode: 78194644). Individuals may access the live teleconference from the investor relations section of the ServiceNow website at http://investors.servicenow.com.

An audio replay of the conference call and webcast will be available two hours after its completion and will be accessible for 30 days. To hear the replay, interested parties may go to the investor relations section of the ServiceNow website or dial 888.286.8010 (passcode: 60952020), or if outside North America, by dialing 617.801.6888 (passcode: 60952020).

About ServiceNow

ServiceNow is the enterprise IT cloud company. We focus on transforming enterprise IT by automating and standardizing business processes and consolidating IT across the global enterprise. Organizations deploy our service to create a single system of record for enterprise IT, lower operational costs and enhance efficiency. Additionally, our customers use our extensible platform to build custom applications for automating activities unique to their business requirements. For more information, visit www.servicenow.com.

ServiceNow and the ServiceNow logo are registered trademarks of ServiceNow. All other brand and product names are trademarks or registered trademarks of their respective holders.

Media Contacts:
ServiceNow
Liza S. Goldberg, 408-851-8553
liza.goldberg@servicenow.com
or
Schwartz MSL
Kim McCrossen, 781-684-6253
servicenow@schwartzmsl.com
or
Investor Contact:
ir@servicenow.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article ServiceNow to Announce First Quarter 2013 Financial Results on Wednesday, April 24, 2013 originally appeared on Fool.com.

Try any of our Foolish newsletter …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

A.P. Pharma Receives FDA Complete Response Letter for APF530

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

A.P. Pharma Receives FDA Complete Response Letter for APF530

– Company Revises Projected Launch Timing from 2H 2013 to 1H 2014 –

– Conference Call to Be Held at 8:30 a.m. Eastern Time –

REDWOOD CITY, Calif.–(BUSINESS WIRE)– A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV). The CRL describes the following issues that must be addressed.

  • With respect to chemistry, manufacturing and controls (CMC), the FDA has requested the refinement of one product quality analytical test method, and that certain deficiencies identified during facility pre-approval inspections be addressed.
  • The FDA has requested that a human factors validation study evaluating the usability of the APF530 syringe system together with its proposed product labeling and instructions for use be conducted with product assembled using a validated, commercial process.
  • With respect to clinical, the FDA has requested a re-analysis of the existing Phase 3 clinical data that reclassifies patients into those receiving moderately emetogenic chemotherapy (MEC) and highly emetogenic chemotherapy (HEC) according to the recently modified ASCO 2011 Guideline. The FDA did not request any new clinical studies.

“We appreciate the FDA‘s thorough review of the APF530 NDA,” stated John B. Whelan, A.P. Pharma’s president and chief executive officer. “While disappointed in today’s notification, we believe that the issues raised in the CRL are addressable, and we remain firmly committed to the successful development of APF530, which we believe will fulfill an important unmet need and improve the lives of patients suffering from CINV. In order to allow us time to carefully address the issues raised in the CRL, we are now projecting product launch for the first half of 2014, versus our prior guidance of the second half of 2013.”

Conference Call Details

A.P. Pharma will host a conference call on Thursday, March 28, 2013 at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). Interested investors may participate in …read more
Source: FULL ARTICLE at DailyFinance